Home / Technical Content / Enzymes to Enable a Biocatalytic Cascade for Small Molecule API
Enzymes to Enable a Biocatalytic Cascade for Small Molecule API

Enzymes to Enable a Biocatalytic Cascade
For Small Molecule API
Enonereductases (EREDs) and ketoreductases (KREDs) are selective, sustainable alternatives to traditional asymmetric hydrogenation. We developed an ERED/KRED enzymatic cascade to install two stereocenters on a cyclohexyl ring in the synthesis of BMS-986278, a potent LPA1 antagonist. Protein engineering and process optimization led to major efficiency gains and a four-fold reduction in PMI compared to the original non-biocatalytic route. This innovation was recognized with the 2023 Peter J. Dunn Award for its significant green chemistry impact.
Gated content
Please complete the form below to access this content.
Discover the Expertise Powering Possibility
Speak to our experts to learn how our platforms deliver smarter science, faster timelines, and greater confidence. Let’s talk.

Related content
Pharmaceutical Biocatalysis
Enzyme Screening Kits and Panels
Tailored Enzymes
Want to see more technical content?






We're Paving Your Path to the Future
You own the product and we own the path. Together, we’ll take it to market clearly, cleanly and without surprises.
